Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300
Steven R. Grossman,124*Maria E. Deato,1Chrystelle Brignone,1*Ho Man Chan,1Andrew L. Kung,135Hideaki Tagami,1Yoshihiro Nakatani,16David M. Livingston147
Rapid turnover of the tumor suppressor protein p53
requires the MDM2 ubiquitin ligase, and both interact with
p300-CREB-bindingprotein transcriptional coactivator
proteins. p53 is stabilizedby the binding of p300 to the oncoprotein
E1A, suggesting thatp300 regulates p53 degradation. Purified p300
exhibited intrinsicubiquitin ligase activity that was inhibited by
E1A. In vitro,p300 with MDM2 catalyzed p53 polyubiquitination, whereas
MDM2catalyzed p53 monoubiquitination. E1A expression caused a
decreasein polyubiquitinated but not monoubiquitinated p53 in cells.
Thus,generation of the polyubiquitinated forms of p53 that are
targetedfor proteasome degradation requires the intrinsic ubiquitin
ligaseactivities of MDM2 and p300.
1 Department of Cancer Biology,
2 Department of Adult Oncology,
3 Department of Pediatric Oncology, Dana-Farber
Cancer Institute, Boston, MA 02115, USA.
4 Department of Medicine,
5 Department of Pediatrics,
6 Department of Biological Chemistry and Molecular
Pharmacology,
7 Department of Genetics, Harvard
Medical School, Boston, MA 02115, USA.
*
Present address: Department of Cancer Biology, University of
Massachusetts Medical School, 364 Plantation Street, Worcester,MA
01605, USA.
Present address: Department of Molecular and Cell
Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
To whom correspondence should be addressed. E-mail:
david_livingston{at}dfci.harvard.edu
The editors suggest the following Related Resources on Science sites:
cAMP Response Element-Binding Protein Interacts With and Stimulates the Proteasomal Degradation of the Nuclear Receptor Coactivator GRIP1.
T. Hoang, I. S. Fenne, A. Madsen, O. Bozickovic, M. Johannessen, M. Bergsvag, E. A. Lien, M. R. Stallcup, J. V. Sagen, U. Moens, et al. (2013)
Endocrinology
154, 1513-1527
|Abstract »|Full Text »|PDF »
Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies.
L. N. Micel, J. J. Tentler, P. G. Smith, and G. S. Eckhardt (2013)
J. Clin. Oncol.
31, 1231-1238
|Abstract »|Full Text »|PDF »
BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300.
Y. Liu, M. W. Mayo, A. S. Nagji, E. H. Hall, L. S. Shock, A. Xiao, E. B. Stelow, and D. R. Jones (2013)
Cancer Res.
73, 1308-1317
|Abstract »|Full Text »|PDF »
Stabilization of p53 in Influenza A Virus-infected Cells Is Associated with Compromised MDM2-mediated Ubiquitination of p53.
X. Wang, X. Deng, W. Yan, Z. Zhu, Y. Shen, Y. Qiu, Z. Shi, D. Shao, J. Wei, X. Xia, et al. (2012)
J. Biol. Chem.
287, 18366-18375
|Abstract »|Full Text »|PDF »
The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for Proteasomal Degradation.
S. F. Ahmed, S. Deb, I. Paul, A. Chatterjee, T. Mandal, U. Chatterjee, and M. K. Ghosh (2012)
J. Biol. Chem.
287, 15996-16006
|Abstract »|Full Text »|PDF »
E3Net: A System for Exploring E3-mediated Regulatory Networks of Cellular Functions.
Y. Han, H. Lee, J. C. Park, and G.-S. Yi (2012)
Mol. Cell. Proteomics
11, O111.014076
|Abstract »|Full Text »|PDF »
It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53.
Low-Dose Valproic Acid Enhances Radiosensitivity of Prostate Cancer through Acetylated p53-Dependent Modulation of Mitochondrial Membrane Potential and Apoptosis.
X. Chen, J. Y. C. Wong, P. Wong, and E. H. Radany (2011)
Mol. Cancer Res.
9, 448-461
|Abstract »|Full Text »|PDF »
Regulation of Glucocorticoid Receptor Activity by a Stress Responsive Transcriptional Cofactor.
L. Davies, E. Paraskevopoulou, M. Sadeq, C. Symeou, C. Pantelidou, C. Demonacos, and M. Krstic-Demonacos (2011)
Mol. Endocrinol.
25, 58-71
|Abstract »|Full Text »|PDF »
Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.
C. W. Lee, J. C. Ferreon, A. C. M. Ferreon, M. Arai, and P. E. Wright (2010)
PNAS
107, 19290-19295
|Abstract »|Full Text »|PDF »
Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase.
S. Iyappan, H.-P. Wollscheid, A. Rojas-Fernandez, A. Marquardt, H.-C. Tang, R. K. Singh, and M. Scheffner (2010)
J. Biol. Chem.
285, 33065-33072
|Abstract »|Full Text »|PDF »
Transcriptional Regulation by P53.
R. Beckerman and C. Prives (2010)
Cold Spring Harb Perspect Biol
2, a000935
|Abstract »|Full Text »|PDF »
Transcriptional Synergy between Melanoma Antigen Gene Protein-A11 (MAGE-11) and p300 in Androgen Receptor Signaling.
E. B. Askew, S. Bai, A. J. Blackwelder, and E. M. Wilson (2010)
J. Biol. Chem.
285, 21824-21836
|Abstract »|Full Text »|PDF »
Complex Regulation of the Transactivation Function of Hypoxia-inducible Factor-1{alpha} by Direct Interaction with Two Distinct Domains of the CREB-binding Protein/p300.
J. L. Ruas, U. Berchner-Pfannschmidt, S. Malik, K. Gradin, J. Fandrey, R. G. Roeder, T. Pereira, and L. Poellinger (2010)
J. Biol. Chem.
285, 2601-2609
|Abstract »|Full Text »|PDF »
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.
L. M. Thompson, C. T. Aiken, L. S. Kaltenbach, N. Agrawal, K. Illes, A. Khoshnan, M. Martinez-Vincente, M. Arrasate, J. G. O'Rourke, H. Khashwji, et al. (2009)
J. Cell Biol.
187, 1083-1099
|Abstract »|Full Text »|PDF »
Posttranslational Modification of p53: Cooperative Integrators of Function.
D. W. Meek and C. W. Anderson (2009)
Cold Spring Harb Perspect Biol
1, a000950
|Abstract »|Full Text »|PDF »
Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells.
C.-T. Han, N. W. Schoene, and K. Y. Lei (2009)
Am J Physiol Cell Physiol
297, C1188-C1199
|Abstract »|Full Text »|PDF »
CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.
D. Shi, M. S. Pop, R. Kulikov, I. M. Love, A. L. Kung, and S. R. Grossman (2009)
PNAS
106, 16275-16280
|Abstract »|Full Text »|PDF »
The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance.
R. Meller (2009)
Neuroscientist
15, 243-260
|Abstract »|PDF »
Influence of glutamine infusion on ubiquitin, caspase-3, cathepsins L and B, and m-calpain expression in sheep with nutritionally induced metabolic acidosis.
S. L. Greenwood, O. AlZahal, K. C. Swanson, J. C. Matthews, and B. W. McBride (2009)
J Anim Sci
87, 2073-2079
|Abstract »|Full Text »|PDF »
Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
J. C. Ferreon, C. W. Lee, M. Arai, M. A. Martinez-Yamout, H. J. Dyson, and P. E. Wright (2009)
PNAS
106, 6591-6596
|Abstract »|Full Text »|PDF »
Tax1BP1 Interacts with Papillomavirus E2 and Regulates E2-Dependent Transcription and Stability.
X. Wang, S. R. Naidu, F. Sverdrup, and E. J. Androphy (2009)
J. Virol.
83, 2274-2284
|Abstract »|Full Text »|PDF »
Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1{alpha}, Leading to Its Oxygen-Independent Degradation.
M. Y. Koh, B. G. Darnay, and G. Powis (2008)
Mol. Cell. Biol.
28, 7081-7095
|Abstract »|Full Text »|PDF »
Lysosomal Localization of Ubiquitinated Jun Requires Multiple Determinants in a Lysine-27-Linked Polyubiquitin Conjugate.
MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination.
M. Maguire, P. C. Nield, T. Devling, R. E. Jenkins, B. K. Park, R. Polanski, N. Vlatkovic, and M. T. Boyd (2008)
Cancer Res.
68, 3232-3242
|Abstract »|Full Text »|PDF »
Identification of Ubiquitin Ligase Activity of RBCK1 and Its Inhibition by Splice Variant RBCK2 and Protein Kinase C{beta}.
K. Tatematsu, N. Yoshimoto, T. Okajima, K. Tanizawa, and S. Kuroda (2008)
J. Biol. Chem.
283, 11575-11585
|Abstract »|Full Text »|PDF »
Gp78 Cooperates with RMA1 in Endoplasmic Reticulum-associated Degradation of CFTR{Delta}F508.
D. Morito, K. Hirao, Y. Oda, N. Hosokawa, F. Tokunaga, D. M. Cyr, K. Tanaka, K. Iwai, and K. Nagata (2008)
Mol. Biol. Cell
19, 1328-1336
|Abstract »|Full Text »|PDF »
Critical and Functional Regulation of CHOP (C/EBP Homologous Protein) through the N-terminal Portion.
N. Ohoka, T. Hattori, M. Kitagawa, K. Onozaki, and H. Hayashi (2007)
J. Biol. Chem.
282, 35687-35694
|Abstract »|Full Text »|PDF »
A High-Throughput Screen Measuring Ubiquitination of p53 by Human mdm2.
M. F. Murray, A. J. Jurewicz, J. D. Martin, T. F. Ho, Hong Zhang, K. O. Johanson, R. B. Kirkpatrick, Jianhong Ma, L. A. Lor, S. H. Thrall, et al. (2007)
J Biomol Screen
12, 1050-1058
|Abstract »|PDF »
p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma.
C. Zhang, K. Li, L. Wei, Z. Li, P. Yu, L. Teng, K. Wu, and J. Zhu (2007)
J. Clin. Pathol.
60, 1249-1253
|Abstract »|Full Text »|PDF »
Quantitative Profiling of Ubiquitylated Proteins Reveals Proteasome Substrates and the Substrate Repertoire Influenced by the Rpn10 Receptor Pathway.
T. Mayor, J. Graumann, J. Bryan, M. J. MacCoss, and R. J. Deshaies (2007)
Mol. Cell. Proteomics
6, 1885-1895
|Abstract »|Full Text »|PDF »
Stabilization of p53 in Human Cytomegalovirus-initiated Cells Is Associated with Sequestration of HDM2 and Decreased p53 Ubiquitination.
Z. Chen, E. Knutson, S. Wang, L. A. Martinez, and T. Albrecht (2007)
J. Biol. Chem.
282, 29284-29295
|Abstract »|Full Text »|PDF »
Negative regulation of the SH2-homology-containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein.
J. Cheng, A. R. Kydd, K. Nakase, K. M. Noonan, A. Murakami, H. Tao, M. Dwyer, C. Xu, Q. Zhu, and W. A. Marasco (2007)
Blood
110, 2110-2120
|Abstract »|Full Text »|PDF »
Induction of Cullin 7 by DNA damage attenuates p53 function.
P. Jung, B. Verdoodt, A. Bailey, J. R. Yates III, A. Menssen, and H. Hermeking (2007)
PNAS
104, 11388-11393
|Abstract »|Full Text »|PDF »
p300 Protein Acetyltransferase Activity Suppresses Systemic Lupus Erythematosus-Like Autoimmune Disease in Mice.
N. Forster, S. Gallinat, J. Jablonska, S. Weiss, H.-P. Elsasser, and W. Lutz (2007)
J. Immunol.
178, 6941-6948
|Abstract »|Full Text »|PDF »
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.
PACT is a negative regulator of p53 and essential for cell growth and embryonic development.
L. Li, B. Deng, G. Xing, Y. Teng, C. Tian, X. Cheng, X. Yin, J. Yang, X. Gao, Y. Zhu, et al. (2007)
PNAS
104, 7951-7956
|Abstract »|Full Text »|PDF »
The N-terminal domain of the Aurora-A Phe-31 variant encodes an E3 ubiquitin ligase and mediates ubiquitination of I{kappa}B{alpha}.
P. Briassouli, F. Chan, and S. Linardopoulos (2006)
Hum. Mol. Genet.
15, 3343-3350
|Abstract »|Full Text »|PDF »
The Pure Estrogen Receptor Antagonist ICI 182,780 Promotes a Novel Interaction of Estrogen Receptor-{alpha} with the 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein-Binding Protein/p300 Coactivators.
B. M. Jaber, T. Gao, L. Huang, S. Karmakar, and C. L. Smith (2006)
Mol. Endocrinol.
20, 2695-2710
|Abstract »|Full Text »|PDF »
Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer.
Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation.
R. Kulikov, M. Winter, and C. Blattner (2006)
J. Biol. Chem.
281, 28575-28583
|Abstract »|Full Text »|PDF »
Regulation of the MDM2-p53 Pathway by Ribosomal Protein L11 Involves a Post-ubiquitination Mechanism.
M.-S. Dai, D. Shi, Y. Jin, X.-X. Sun, Y. Zhang, S. R. Grossman, and H. Lu (2006)
J. Biol. Chem.
281, 24304-24313
|Abstract »|Full Text »|PDF »
The Human Orthologue of Drosophila Ecdysoneless Protein Interacts with p53 and Regulates Its Function..
Y. Zhang, C. B. Gurumurthy, J. Kim, I. Bhat, Q. Gao, G. Dimri, S. W. Lee, H. Band, and V. Band (2006)
Cancer Res.
66, 7167-7175
|Abstract »|Full Text »|PDF »
Jab1 Induces the Cytoplasmic Localization and Degradation of p53 in Coordination with Hdm2.
W. Oh, E.-W. Lee, Y. H. Sung, M.-R. Yang, J. Ghim, H.-W. Lee, and J. Song (2006)
J. Biol. Chem.
281, 17457-17465
|Abstract »|Full Text »|PDF »
HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells.
A. Parcellier, M. Brunet, E. Schmitt, E. Col, C. Didelot, A. Hammann, K. Nakayama, K. I. Nakayama, S. Khochbin, E. Solary, et al. (2006)
FASEB J
20, 1179-1181
|Abstract »|Full Text »|PDF »
Nuclear Accumulations of p53 and Mdm2 Are Accompanied by Reductions in c-Abl and p300 in Zinc-Depleted Human Hepatoblastoma Cells.
A. A. Alshatwi, C.-T. Han, N. W. Schoene, and K. Y. Lei (2006)
Experimental Biology and Medicine
231, 611-618
|Abstract »|Full Text »|PDF »
Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway..
X. Yang, M. Fraser, U. M. Moll, A. Basak, and B. K. Tsang (2006)
Cancer Res.
66, 3126-3136
|Abstract »|Full Text »|PDF »
Interferon-Inducible Protein IFIX{alpha}1 Functions as a Negative Regulator of HDM2.
Y. Ding, J.-F. Lee, H. Lu, M.-H. Lee, and D.-H. Yan (2006)
Mol. Cell. Biol.
26, 1979-1996
|Abstract »|Full Text »|PDF »
Overexpression of the Coactivator Bridge-1 Results in Insulin Deficiency and Diabetes.
J. L. Volinic, J. H. Lee, K. Eto, V. Kaur, and M. K. Thomas (2006)
Mol. Endocrinol.
20, 167-182
|Abstract »|Full Text »|PDF »
Ubiquitination of p53 at Multiple Sites in the DNA-Binding Domain.
W. M. Chan, M. C. Mak, T. K. Fung, A. Lau, W. Y. Siu, and R. Y.C. Poon (2006)
Mol. Cancer Res.
4, 15-25
|Abstract »|Full Text »|PDF »
p300 Modulates ATF4 Stability and Transcriptional Activity Independently of Its Acetyltransferase Domain.
I. Lassot, E. Estrabaud, S. Emiliani, M. Benkirane, R. Benarous, and F. Margottin-Goguet (2005)
J. Biol. Chem.
280, 41537-41545
|Abstract »|Full Text »|PDF »
Dual Regulation of c-Myc by p300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription.
F. Faiola, X. Liu, S. Lo, S. Pan, K. Zhang, E. Lymar, A. Farina, and E. Martinez (2005)
Mol. Cell. Biol.
25, 10220-10234
|Abstract »|Full Text »|PDF »
Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1.
J. H Lee, J. L Volinic, C. Banz, K.-M. Yao, and M. K Thomas (2005)
J. Endocrinol.
187, 283-292
|Abstract »|Full Text »|PDF »
Role of the UBL-UBA Protein KPC2 in Degradation of p27 at G1 Phase of the Cell Cycle.
T. Hara, T. Kamura, S. Kotoshiba, H. Takahashi, K. Fujiwara, I. Onoyama, M. Shirakawa, N. Mizushima, and K. I. Nakayama (2005)
Mol. Cell. Biol.
25, 9292-9303
|Abstract »|Full Text »|PDF »
Cross Talk in Hormonally Regulated Gene Transcription through Induction of Estrogen Receptor Ubiquitylation.
M. Luo, M. Koh, J. Feng, Q. Wu, and P. Melamed (2005)
Mol. Cell. Biol.
25, 7386-7398
|Abstract »|Full Text »|PDF »
ING2 Regulates the Onset of Replicative Senescence by Induction of p300-Dependent p53 Acetylation.
R. Pedeux, S. Sengupta, J. C. Shen, O. N. Demidov, S. Saito, H. Onogi, K. Kumamoto, S. Wincovitch, S. H. Garfield, M. McMenamin, et al. (2005)
Mol. Cell. Biol.
25, 6639-6648
|Abstract »|Full Text »|PDF »
A Chromatin-associated and Transcriptionally Inactive p53-Mdm2 Complex Occurs in mdm2 SNP309 Homozygous Cells.
N. C. Arva, T. R. Gopen, K. E. Talbott, L. E. Campbell, A. Chicas, D. E. White, G. L. Bond, A. J. Levine, and J. Bargonetti (2005)
J. Biol. Chem.
280, 26776-26787
|Abstract »|Full Text »|PDF »
The Chaperone-associated Ubiquitin Ligase CHIP Is Able to Target p53 for Proteasomal Degradation.
C. Esser, M. Scheffner, and J. Hohfeld (2005)
J. Biol. Chem.
280, 27443-27448
|Abstract »|Full Text »|PDF »
Involvement of Nuclear Export in Human Papillomavirus Type 18 E6-Mediated Ubiquitination and Degradation of p53.
A. V. Samuelson, M. Narita, H.-M. Chan, J. Jin, E. de Stanchina, M. E. McCurrach, M. Narita, M. Fuchs, D. M. Livingston, and S. W. Lowe (2005)
J. Biol. Chem.
280, 21915-21923
|Abstract »|Full Text »|PDF »
Recruitment of CBP/p300, TATA-Binding Protein, and S8 to Distinct Regions at the N Terminus of Adenovirus E1A.
M. Rasti, R. J. A. Grand, J. S. Mymryk, P. H. Gallimore, and A. S. Turnell (2005)
J. Virol.
79, 5594-5605
|Abstract »|Full Text »|PDF »
Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.
H K Kinyamu, J Chen, and T K Archer (2005)
J. Mol. Endocrinol.
34, 281-297
|Abstract »|Full Text »|PDF »
SIRT1 Deacetylation and Repression of p300 Involves Lysine Residues 1020/1024 within the Cell Cycle Regulatory Domain 1.
T. Bouras, M. Fu, A. A. Sauve, F. Wang, A. A. Quong, N. D. Perkins, R. T. Hay, W. Gu, and R. G. Pestell (2005)
J. Biol. Chem.
280, 10264-10276
|Abstract »|Full Text »|PDF »
Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development.
W. J. Weninger, K. L. Floro, M. B. Bennett, S. L. Withington, J. I. Preis, J. P. M. Barbera, T. J. Mohun, and S. L. Dunwoodie (2005)
Development
132, 1337-1348
|Abstract »|Full Text »|PDF »
B56 Regulatory Subunit of Protein Phosphatase 2A Mediates Valproic Acid-Induced p300 Degradation.
Effects of Depletion of CREB-binding Protein on c-Myc Regulation and Cell Cycle G1-S Transition.
H. N. Rajabi, S. Baluchamy, S. Kolli, A. Nag, R. Srinivas, P. Raychaudhuri, and B. Thimmapaya (2005)
J. Biol. Chem.
280, 361-374
|Abstract »|Full Text »|PDF »
Cul4A Physically Associates with MDM2 and Participates in the Proteolysis of p53.
Topors Functions as an E3 Ubiquitin Ligase with Specific E2 Enzymes and Ubiquitinates p53.
R. Rajendra, D. Malegaonkar, P. Pungaliya, H. Marshall, Z. Rasheed, J. Brownell, L. F. Liu, S. Lutzker, A. Saleem, and E. H. Rubin (2004)
J. Biol. Chem.
279, 36440-36444
|Abstract »|Full Text »|PDF »
YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
E. Gronroos, A. A. Terentiev, T. Punga, and J. Ericsson (2004)
PNAS
101, 12165-12170
|Abstract »|Full Text »|PDF »
Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner.
Y.-H. Jin, E.-J. Jeon, Q.-L. Li, Y. H. Lee, J.-K. Choi, W.-J. Kim, K.-Y. Lee, and S.-C. Bae (2004)
J. Biol. Chem.
279, 29409-29417
|Abstract »|Full Text »|PDF »
Multiple Interactions of Rad23 Suggest a Mechanism for Ubiquitylated Substrate Delivery Important in Proteolysis.
The Targeting of the Proteasomal Regulatory Subunit S2 by Adenovirus E1A Causes Inhibition of Proteasomal Activity and Increased p53 Expression.
X. Zhang, A. S. Turnell, C. Gorbea, J. S. Mymryk, P. H. Gallimore, and R. J. A. Grand (2004)
J. Biol. Chem.
279, 25122-25133
|Abstract »|Full Text »|PDF »
p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels.
N. G. Iyer, S.-F. Chin, H. Ozdag, Y. Daigo, D.-E. Hu, M. Cariati, K. Brindle, S. Aparicio, and C. Caldas (2004)
PNAS
101, 7386-7391
|Abstract »|Full Text »|PDF »
MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation.
Y. Jin, S. X. Zeng, H. Lee, and H. Lu (2004)
J. Biol. Chem.
279, 20035-20043
|Abstract »|Full Text »|PDF »
TSG101 Interacts with Apoptosis-antagonizing Transcription Factor and Enhances Androgen Receptor-mediated Transcription by Promoting Its Monoubiquitination.
S. Burgdorf, P. Leister, and K. H. Scheidtmann (2004)
J. Biol. Chem.
279, 17524-17534
|Abstract »|Full Text »|PDF »
Control of Human PIRH2 Protein Stability: INVOLVEMENT OF TIP60 AND THE PROTEASOME.
I. R. Logan, V. Sapountzi, L. Gaughan, D. E. Neal, and C. N. Robson (2004)
J. Biol. Chem.
279, 11696-11704
|Abstract »|Full Text »|PDF »
Participation of the Ubiquitin-Conjugating Enzyme UBE2E3 in Nedd4-2-Dependent Regulation of the Epithelial Na+ Channel.